Mario Balsa, Medical Oncology Resident at Catalan Institute of Oncology, shared on X:
“Clinical toxicity of ADCs and ICI–ADC combinations.
Unified framework separating immune-, payload- and target-related toxicities
Recognize organ-specific toxicity patterns and manage overlapping ICI–ADC toxicities as immune-mediated until proven otherwise Practical algorithms for treatment interruption and rechallenge!
The real payload isn’t just the drug, it’s knowing who carries the toxicity
Congrats to Solange Peters, Petros Grivas, Sara Tolaney and all the team! amazing.”
Petros Grivas, Professor and Physician-Scientist in Genitourinary Cancers at the University of Washington and Fred Hutch, shared a post on X by Mario Balsa, adding:
“Excited to be part of this comprehensive article reviewing toxicity of ADCs & ICI-ADC combos! Thanks Michel Obeid for leading this effort with our friends Solange Peters, Christophe Massard, Sara Tolaney so important topic.”
Tilte: Clinical toxicity of ADCs and ICI–ADC combinations: mechanisms, patterns and management
Authors: Solange Peters, Petros Grivas, Christophe Massard, Sara M. Tolaney, Michel Obeid
Read the Full Article.
Other articles featuring Mario Balsa on OncoDaily.